Mammary Paget’s disease is a rare breast cancer that affects the nipple and areola skin. People with Mammary Paget’s disease often notice itching, burning, flaking skin, or a flat or inverted nipple. It tends to be long‑lasting without treatment and is most often found in adults, usually after age 40. Many people first hear about Mammary Paget’s disease when a nipple rash does not improve with usual creams. Treatment usually includes surgery and may include radiation, hormone therapy, or chemotherapy, and outlook depends on whether there is an underlying breast tumor and how early it is found.
Overview
Mammary paget's diseaseSymptoms
Early symptoms of Mammary Paget's disease include persistent itching, burning, and tenderness of one nipple with red, scaly, or crusted skin. You may notice discharge, bleeding, or nipple flattening/inversion. Some develop a breast lump or enlarged underarm nodes.
Outlook and prognosis
Most people with Mammary Paget’s disease do well when it’s found early and treated, especially if cancer is limited to the nipple and nearby ducts. Outcomes depend on whether there’s an underlying breast tumor and if lymph nodes are involved. Regular follow-up imaging and exams help catch any changes promptly.
Causes and risk factors
Mammary Paget's disease usually arises from underlying breast cancer cells spreading to the nipple skin. Risk factors mirror breast cancer: older age, female sex, family or personal history, BRCA mutations, prior chest radiation, alcohol, obesity, and prolonged estrogen exposure.
Genetic influences
Genetics play a limited role in Mammary Paget’s disease. Most cases arise from non-inherited changes linked to underlying breast cancer in the ducts. Inherited variants (like BRCA1/2) can raise overall breast cancer risk, indirectly increasing Paget’s likelihood.
Diagnosis
The diagnosis of Mammary Paget's disease starts with breast and nipple examination and imaging, usually mammogram and ultrasound, sometimes MRI. Confirmation comes from a skin or core needle biopsy, and tests check for underlying breast cancer.
Treatment and drugs
Treatment for Mammary Paget’s disease usually combines breast surgery tailored to the cancer’s extent with careful attention to appearance and comfort. Many also receive radiation, anti‑hormone tablets if the tumor is hormone‑sensitive, and sometimes chemotherapy or HER2‑targeted therapy. Ongoing follow‑up supports healing, skin care, and recovery.
Symptoms
People often first notice a stubborn rash or irritation on one nipple that doesn’t fully clear. You might notice small changes at first—itching, burning, or flaking that returns after moisturizers or steroid creams. Early symptoms of Mammary Paget's disease can include nipple skin changes, discharge, or tenderness. These changes may be mild at the start but tend to persist on one side.
Red, scaly, or flaky skin on the nipple or areola can develop and look like eczema. It tends to persist or return despite creams.
The nipple or areola may itch, tingle, or burn. These sensations can come and go but usually stay on one side.
Clear, yellow, or bloody fluid can leak from the nipple. It may happen without squeezing and often persists.
The nipple may flatten, turn inward, or lose its normal shape. This change can happen gradually and affect one breast.
How people usually first notice Mammary paget's disease?
People often first notice Mammary Paget’s disease as a persistent change on one nipple that looks like eczema: redness, flaking, or a scaly, itchy rash that may ooze or form a crust and doesn’t fully clear with moisturizers or steroid creams. Over time, there may be burning, tenderness, or the nipple may flatten, invert, or develop a small ulcer, and some notice a spot of bloody or straw-colored discharge. These first signs of Mammary Paget’s disease usually appear on one side and can be subtle, which is why a nonhealing “eczema-like” patch limited to one nipple-areola area should prompt medical evaluation.
Types of Mammary paget's disease
Mammary Paget’s disease has a few well-recognized clinical variants that differ mainly in how the nipple–areola area looks and whether an underlying breast tumor is present. Some types show up primarily on the skin surface, while others are linked to a deeper cancer behind the nipple. Symptoms don’t always look the same for everyone. Knowing the key variants can help people and clinicians talk clearly about the types of Mammary Paget’s disease they’re dealing with.
Isolated Paget changes
The nipple–areola skin shows eczemalike changes without a detectable mass in the breast. People may notice redness, scaling, itching, or a burning feeling mainly on the nipple. Early symptoms of Mammary Paget’s disease can look like stubborn eczema that doesn’t respond to creams.
With underlying DCIS
The nipple skin changes occur along with ductal carcinoma in situ behind the nipple. Symptoms on the surface may mirror the isolated type, but imaging or biopsy finds noninvasive cancer in the ducts. Treatment planning often focuses on removing the affected ducts while checking the rest of the breast.
With invasive cancer
The nipple–areola changes happen alongside an invasive breast cancer in the same breast. People may find a firm lump, thicker skin, or discharge in addition to the surface rash. This variant tends to bring fuller staging workup and broader treatment options.
Bilateral presentation
Both nipples are affected at the same time, which is rare. Skin symptoms usually appear on each side, sometimes at different intensities. Clinicians often investigate carefully to rule out separate underlying tumors in each breast.
Pigmented Paget variant
The nipple–areola looks darker or patchy rather than only red and scaly. It can resemble melanoma or other pigmented rashes on first glance. Diagnosis relies on a biopsy to confirm Paget cells and guide next steps.
What genetics can tell you about symptoms
Some people with mammary Paget’s disease have changes in genes like HER2 that act like a stuck accelerator, driving abnormal skin changes of the nipple-areola with burning, itching, or oozing. These genetic shifts also link to underlying ductal breast cancer, causing redness, scaling, and nipple inversion.
Causes and risk factors
In most cases, Mammary Paget's disease happens when breast cancer cells travel through the milk ducts to the nipple skin, though it can rarely start in the nipple skin itself. Risk factors for Mammary Paget's disease are similar to those for other breast cancers. Age and female sex raise risk, and family history or inherited BRCA1 or BRCA2 changes can too. Regular alcohol use, higher body weight, long-term menopausal hormone therapy, and prior chest radiation may add risk. Doctors distinguish between risk factors you can change and those you can’t.
Environmental and biological risk factors
People often want to know what in their body or surroundings might raise the chance of Mammary Paget's disease. Doctors often group risks into internal (biological) and external (environmental). Because this condition is usually linked to cancer cells in the milk ducts, factors that raise breast cancer risk can also make Paget’s more likely. These risks don’t predict early symptoms of Mammary Paget's disease, but they can point to who may benefit from closer breast evaluation.
Risk rises with age, with most cases diagnosed after midlife. Breast tissue changes over time can make ductal cancers—and with them Paget’s changes at the nipple—more likely.
Most cases occur in people with female breast tissue. Mammary Paget's disease can occur in men, but it is rare.
Mammary Paget's disease often happens when cancer cells in the milk ducts spread up to the nipple. Having ductal carcinoma in situ or invasive ductal cancer in that breast increases the chance of nipple involvement.
Certain noncancerous findings, such as atypical hyperplasia, signal a higher chance of later breast cancer. Because the disease is usually tied to ductal cancer, these changes indirectly raise Paget’s likelihood.
Genetic risk factors
Most cases of Mammary Paget's disease arise from a ductal breast cancer beneath the nipple, so the same genetic changes driving that cancer often drive the nipple-areola changes. These changes are typically acquired in the tumor (somatic), not inherited in the family. Some risk factors are inherited through our genes. Inherited variants that raise ductal breast cancer risk, such as BRCA1 or BRCA2, can indirectly increase the chance that Paget’s is how the cancer first shows up.
HER2 amplification: Paget cells and the underlying tumor commonly show extra copies and high activity of the HER2 gene. This acquired change can help tumor cells travel along the ducts to the nipple skin. It is a tumor finding rather than an inherited trait.
PIK3CA mutations: Some underlying ductal cancers and matching Paget cells carry activating changes in the PIK3CA gene. These somatic mutations turn on growth pathways that support tumor survival.
TP53 changes: Changes in the TP53 gene are found in a subset of cases and reflect genomic instability in the tumor. These are usually somatic changes within the cancer, not passed down in families.
Shared tumor origin: Genetic profiles of nipple Paget cells often mirror the underlying ductal carcinoma. This supports the idea that Mammary Paget's disease represents spread of those cancer cells into the nipple skin.
BRCA1/BRCA2 variants: Inherited variants strongly raise lifetime risk of ductal breast cancer, so they can also raise the chance that Mammary Paget's disease is the first sign. Carrying a genetic change doesn’t guarantee the condition will appear.
PALB2/CHEK2 variants: Inherited changes in these moderate-risk genes increase the chance of ductal breast cancer. Because Paget changes usually track with ductal tumors, these variants may indirectly increase Mammary Paget's disease risk.
PTEN/TP53 syndromes: Rare inherited conditions like Cowden syndrome (PTEN) or Li-Fraumeni syndrome (TP53) raise breast cancer risk. When cancer develops, nipple–areola Paget changes can be how it first presents.
Family history: Multiple relatives with early or bilateral breast cancer suggests a higher chance of a hereditary predisposition gene. Genetic counseling and testing can clarify the hereditary risk of Mammary Paget's disease.
Lifestyle risk factors
Mammary paget's disease is usually linked to an underlying breast cancer of the nipple–areola complex, so lifestyle patterns that raise or lower breast cancer risk likely influence this condition. While no lifestyle habit directly causes it, choices can shift risk in meaningful ways. Understanding the lifestyle risk factors for Mammary paget's disease can guide prevention-focused habits.
Regular drinking increases circulating estrogens and breast cancer risk, which likely raises risk of Mammary paget's disease. Even low-to-moderate intake can add risk over time.
Overweight and obesity, especially after menopause, increase estrogen and inflammation that drive breast tumors linked to Paget’s changes. Keeping weight in a healthy range may lower risk.
Too little moderate-to-vigorous activity is tied to higher breast cancer risk and therefore a higher chance of Paget’s of the nipple. Consistent movement can help regulate hormones and insulin.
Diets high in alcohol, ultra-processed foods, and saturated fats are associated with higher breast cancer risk and may elevate Paget’s risk. Emphasizing fiber-rich plant foods may be protective.
Risk prevention
You can’t fully prevent Mammary Paget’s disease, but you can lower overall breast cancer risk and catch changes earlier. Prevention is about lowering risk, not eliminating it completely. Pay close attention to nipple and areola symptoms—itching, burning, flaking skin, discharge, or a newly inverted nipple—since early symptoms of Mammary Paget’s disease can be subtle. Regular screening and quick evaluation of new breast or nipple changes give the best chance of finding problems early.
Keep up with age- and risk-based mammograms and clinical breast exams. For those at higher risk, ask if MRI should be added.
Watch for new nipple or areola changes like redness, scaling, discharge, or persistent itching. Report changes that last more than a few weeks to your doctor.
If a “rash” on the nipple doesn’t clear with simple care, get it checked. Early assessment helps rule out or confirm Mammary Paget’s disease sooner.
Share any breast or ovarian cancer in relatives with your clinician. This helps tailor your screening plan and timing.
Transmission
Mammary Paget’s disease is a form of breast cancer that affects the nipple and areola; it cannot be transferred from one person to another and is not contagious. It does not spread through touch, kissing, sexual activity, shared clothing, or breastfeeding; cancer cells do not pass to a baby through breast milk.
Most cases are not inherited; while an inherited gene change (such as BRCA1 or BRCA2) can raise overall breast cancer risk in a family, genetic transmission of Mammary Paget’s disease itself is uncommon. In practical terms, how Mammary Paget’s disease is transmitted is not a concern—focus is on timely diagnosis and treatment rather than avoiding exposure.
When to test your genes
Consider genetic testing if you have a strong family history of breast or related cancers (especially multiple relatives, early diagnoses, or known BRCA1/BRCA2/TP53 variants), or if Mammary Paget’s disease appears before menopause. Testing can guide screening intensity and preventive options for you and relatives. A genetics professional can tailor recommendations.
Diagnosis
Mammary Paget's disease often first shows up as a stubborn, itchy, or scaly change on the nipple or areola that just doesn’t heal. Doctors usually begin with a close look at the skin and a careful breast exam, then use imaging and a small skin sample to confirm what’s going on. Because these changes can mimic eczema, a focused workup helps avoid delays. You may hear this called the diagnosis of Mammary Paget's disease, which pulls together exam findings, imaging, and biopsy results.
A clinician looks closely at the nipple–areola skin and checks both breasts and armpit areas for lumps or tenderness. They note features like crusting, color change, oozing, or ulceration that raise concern for Paget’s.
A specialist may assess the rash to distinguish it from eczema or infection. Features that persist despite moisturizers or steroid creams prompt further testing.
X‑rays of both breasts look for calcifications or a hidden mass under the nipple area. This helps detect duct changes or cancers that can accompany Paget’s.
Sound waves check the area behind the nipple and any spot that feels different. It can reveal a mass or duct changes that a mammogram might miss in dense tissue.
Stages of Mammary paget's disease
Mammary paget's disease does not have defined progression stages. It acts more like a warning sign on the nipple–areola that’s linked to an underlying breast cancer, so staging follows the tumor (whether it’s in situ or invasive and whether lymph nodes are involved) rather than the skin changes themselves. Because early symptoms of Mammary Paget's disease can look like simple eczema—itching, flaking, or redness—diagnosis usually relies on a careful exam and a small skin biopsy of the nipple to check for cancer cells. Different tests may be suggested to help evaluate the rest of the breast, such as a mammogram, ultrasound, or MRI, and to plan the right treatment.
Outlook and prognosis
Looking at the long-term picture can be helpful. Many people with Mammary Paget’s disease do well when it’s found and treated early, especially if the abnormal cells are limited to the nipple and the surface skin. Early care can make a real difference, because outcomes are closely tied to whether there’s an underlying breast cancer deeper in the tissue or ducts. When the disease is confined to the nipple–areola area (without invasive cancer), surgery to remove the affected area—sometimes with breast-conserving approaches—often leads to excellent control and a high chance of long-term survival.
The outlook is not the same for everyone, but it largely depends on the stage and type of any associated breast cancer and whether lymph nodes are involved. If invasive cancer is present or lymph nodes contain cancer cells, doctors may recommend additional treatments like radiation, hormone therapy, or chemotherapy, and the prognosis reflects those factors. For many, this can mean years of remission and routine follow-up; for others with more advanced disease at diagnosis, the risk of recurrence is higher. People often ask about early symptoms of Mammary Paget’s disease—like a persistent, itchy, scaly rash on the nipple—because catching these signs and getting checked promptly can improve the long-term outlook.
Prognosis refers to how a condition tends to change or stabilize over time. Five-year survival is generally very high when Mammary Paget’s disease is diagnosed early and not linked to invasive cancer, and it decreases as stage increases if invasive disease is found. With ongoing care, many people maintain a good quality of life, return to usual activities, and keep regular breast screenings to watch for recurrence. Talk with your doctor about what your personal outlook might look like, including stage, tumor features, lymph node status, and treatments that fit your goals.
Long-term effects
Mammary Paget's disease is a form of breast cancer that starts on the nipple and areola and is often linked to a tumor deeper in the breast. What happens in the long run depends on how early it’s found, the tumor’s features, and the treatments used. Understanding long-term patterns can guide treatment choices. When caught early, the long-term prognosis of Mammary Paget's disease is generally better, with fewer complications and a lower chance of spread.
The cancer can return in the treated breast, the chest wall, or nearby lymph nodes. Ongoing follow-up imaging and skin checks help find changes early.
After lymph node surgery or radiation, the arm on that side can swell (lymphedema). It may feel heavy, tight, or achy and can fluctuate over time.
Nipple and areola feeling can be reduced or lost, especially if the nipple is removed. Some people have tingling, burning, or nerve pain that lingers after surgery.
Scarring and changes in breast shape or size are common after surgery and radiation. The treated side may look or feel different than the other breast.
How is it to live with Mammary paget's disease?
Living with mammary Paget’s disease often starts with something that seems small—a stubborn, itchy, scaly change on the nipple or areola that doesn’t heal—yet it can carry the emotional weight of a breast cancer workup and treatment. Day to day, people may juggle skin discomfort, sensitivity to clothing, and appointments for imaging, biopsies, and surgery, followed by recovery and possible radiation; fatigue and body-image concerns are common but usually ease with good support and clear care plans. Partners, family, and close friends often feel worried too, and they can be a powerful source of practical help—from rides to appointments to reminders for wound care—when guided by what you find helpful. Many find that learning what to expect, asking questions early, and connecting with others who’ve been through it turns a frightening unknown into a navigable path.
Treatment and drugs
Treatment for Mammary Paget’s disease focuses on removing the affected tissue and treating any underlying breast cancer. Many people have surgery; this may be breast-conserving surgery (removing the nipple-areola area and a rim of tissue) with radiation, or a mastectomy if disease is more extensive or there’s cancer elsewhere in the breast. If an underlying tumor is found, treatment often includes radiation therapy, and may also involve medicines like hormone therapy, chemotherapy, or HER2‑targeted drugs, depending on the tumor’s features. Not every treatment works the same way for every person, so your team will tailor the plan to the size and type of cancer, your overall health, and your preferences. Ask your doctor about the best starting point for you, including whether breast reconstruction and nipple-sparing options are appropriate in your case.
Non-drug treatment
For Mammary Paget’s disease, the main non-drug treatments focus on removing the affected area and reducing the chance of the cancer returning. Non-drug treatments often lay the foundation for recovery, with surgery and radiation at the core, and rehabilitation and emotional support helping you heal well. Plans are tailored to the tumor’s size and location, your overall health, and personal preferences. Early symptoms of Mammary Paget’s disease can also guide how precisely the care team plans surgery and skin care.
Surgeons remove the nipple–areola area and the cancer while keeping as much healthy breast as possible. This can be combined with radiation to lower the chance of cancer coming back.
The whole breast is removed when cancer is more extensive or if you prefer a one-step approach. This may be recommended for Mammary Paget’s disease when there is a larger underlying tumor.
A few key lymph nodes are checked and sometimes removed to see if cancer has spread. This helps tailor treatment while limiting the risk of arm swelling.
Targeted beams treat the breast area to kill leftover cancer cells after surgery. For some with Mammary Paget’s disease, radiation can also be used instead of mastectomy when breast-conserving surgery is chosen.
Your genes may have an impact on how drugs work for you
Two people with mammary Paget’s disease can respond very differently to the same drug because genes affect how fast medicines are absorbed, broken down, and cleared. Pharmacogenetic testing may guide safer doses or alternative options, especially for pain control or systemic therapies.
Pharmacological treatments
Most medicines for Mammary Paget’s disease are the same drugs used for breast cancer, chosen based on hormone receptors, HER2 status, and stage. They’re often used alongside surgery and sometimes radiation to lower the chance the cancer comes back or to treat spread. Not everyone responds to the same medication in the same way. Spotting early symptoms of Mammary Paget’s disease can lead to earlier diagnosis and more options for tailored drug therapy.
Tamoxifen or aromatase inhibitors (anastrozole, letrozole, exemestane) help block hormones that fuel hormone‑receptor–positive cancer. These are often taken for 5–10 years to reduce recurrence risk.
Palbociclib, ribociclib, or abemaciclib are added to endocrine therapy for advanced or high‑risk hormone‑positive disease. They can slow cancer growth; blood counts and liver tests are monitored for safety.
Trastuzumab, often with pertuzumab, treats HER2‑positive disease and may be followed by T‑DM1 or trastuzumab deruxtecan if needed. Heart function is checked during treatment because these drugs can affect the heart.
Common regimens use anthracyclines (doxorubicin or epirubicin) and taxanes (paclitaxel or docetaxel), sometimes with carboplatin. These may be given before or after surgery or for metastatic disease to shrink or control cancer.
Genetic influences
People often ask whether Mammary Paget’s disease is hereditary. For most, it isn’t directly passed down; instead, it reflects the same inherited and noninherited factors that shape overall breast cancer risk. Having a genetic risk is not the same as having the disease itself. In families with gene changes that raise breast cancer risk—such as BRCA1 or BRCA2, and less commonly PALB2, TP53, or PTEN—Paget’s changes of the nipple can be one possible way a breast cancer appears, but many with these genes never develop Paget’s disease. At the tumor level, many Paget’s lesions show extra copies of the HER2 gene; this is a change within the cancer cells (not something you were born with) and it can help guide targeted treatment. If you have a strong family history of early breast or ovarian cancer, or you’re wondering “is Mammary Paget’s disease hereditary,” a conversation with a genetic counselor can clarify your personal risk and whether testing makes sense.
Is Mammary paget's disease genetic?
Genetics play a limited role in Mammary Paget’s disease. Most cases arise from non-inherited changes linked to underlying breast cancer in the ducts. Inherited variants (like BRCA1/2) can raise overall breast cancer risk, indirectly increasing Paget’s likelihood.
Pharmacogenetics—how genetics influence drug effects
In Mammary Paget’s disease, drug choices often follow the biology of the underlying breast cancer, especially hormone receptors (estrogen and progesterone) and HER2. These tumor features, which reflect genetic changes in the cancer cells, can point to targeted medicines such as hormone therapy or HER2-directed treatments and influence whether chemotherapy is helpful. Inherited gene changes can matter too: when someone has a BRCA1 or BRCA2 variant, PARP inhibitors may be an option alongside surgery and radiation. For medicines commonly used in breast cancer, differences in drug-processing genes sometimes affect benefit or side effects; DPYD variants can raise the risk of severe reactions with fluorouracil or capecitabine, and CYP2D6 variants can alter how tamoxifen is activated, though testing for tamoxifen isn’t routine everywhere. Not every difference in response is genetic, but doctors may combine tumor profiling with selected genetic tests to tailor treatment and dosing. If you’re considering genetic testing for Mammary Paget’s disease treatment decisions, ask which results would change the plan and how they fit with your overall health and preferences.
Interactions with other conditions
Many living with Mammary Paget’s disease also have an underlying breast cancer in the same breast—most often ductal carcinoma in situ (DCIS) or an invasive cancer—which is what ultimately guides treatment and follow-up. To understand overall health, it’s useful to see how conditions overlap. Skin conditions such as eczema or psoriasis of the nipple can mimic or mask Mammary Paget’s disease; steroid creams may briefly calm the rash or itching but can delay spotting early symptoms of Mammary Paget’s disease that don’t fully go away.
When HER2-targeted medicines are used for the associated breast cancer, pre‑existing heart disease can influence drug choices and monitoring because some therapies can stress the heart. Diabetes or smoking can slow wound healing after breast surgery and may raise the risk of skin infections during radiation. Family history and inherited factors that raise breast cancer risk can also appear in those with Mammary Paget’s disease, so the pattern of risk often mirrors what’s seen with other breast cancers. Coordination between dermatology, breast surgery, oncology, and cardiology helps tailor care when other health issues are in the mix.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described itchy, scaly changes of the nipple that didn’t respond to ointments, only later discovering an underlying breast cancer. Early accounts were often written as skin problems, because the redness and flaking looked like eczema. Many living with Mammary Paget’s disease noticed burning or tingling long before a lump could be felt, and doctors initially focused on the rash they could see rather than the cancer beneath.
First described in the medical literature as a peculiar nipple eruption linked to breast tumors in the late 19th century, the condition gradually became recognized as a surface sign of disease deeper in the breast. At a time when imaging didn’t exist, the diagnosis rested on careful examination and biopsy, which revealed cancer cells extending into the skin of the nipple and areola. Over time, descriptions became more precise, noting that the skin changes often appear on one side, may crust or ooze, and can come and go—misleading both patients and clinicians into thinking it was a simple dermatitis.
As medical science evolved, surgeons and pathologists mapped how Mammary Paget’s disease relates to ductal cancer within the breast. The idea that it was merely a skin condition gave way to the understanding that it’s usually connected to cancer in the milk ducts, even when no lump is obvious. With the arrival of mammography in the mid-20th century and, later, ultrasound and MRI, clinicians could better search for hidden tumors when nipple symptoms appeared. Not every early description was complete, yet together they built the foundation of today’s knowledge.
Treatment history reflects this shift. Early care often involved removal of the entire breast because of the cancer link. As techniques improved, breast-conserving surgery with removal of the nipple–areola area, sentinel lymph node evaluation, and targeted therapies became options for many, tailored to the tumor found beneath. Pathology standards also evolved, clarifying how the cancer cells in the skin look under the microscope and how they differ from ordinary eczema.
In recent decades, awareness has grown that persistent, one-sided nipple eczema in an adult—especially with scaling, burning, or bleeding—warrants evaluation for Mammary Paget’s disease. Today, the history of this condition reminds clinicians and patients to look beyond the surface: a stubborn rash on the nipple can be an early symptom of Mammary Paget’s disease, and timely imaging and biopsy can change the course of care.